Government Documents | Latest

New Zealand HEALTHTECH Report 2024

3 Sep 2024

Over the course of two decades, NZ’s healthtech sector has matured into a multibillion dollar tech-export industry. After reaching peak revenue of $2.9B amid the
pandemic, the sector is again on the up. Read more

Share this post:

X (Twitter) Facebook LinkedIn Email

Medicines industry ‘dodges a bullet’ with tariff exemption – for now

New Zealand’s pharmaceutical sector is cautiously optimistic over the industry being granted an exemption from US President Donald Trump’s tariffs.

Faster approvals for medicines available overseas under new law

The legislation will give the health minister the power to approve, reject or transfer medication applications

Popular weight-loss drug Wegovy receives approval in New Zealand

A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”.

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.